Merrion Pharmaceuticals Plc annonce les résultats préliminaires de l'étude de phase II portant sur Orazol(tm)
20 mai 2009 09h19 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Irlande, 15 mai 2009 (GLOBE NEWSWIRE) - Le docteur John Fox, de la
société Merrion Pharmaceuticals (« Merrion » ou la « Société » ), donnera une
allocution lors de la 7ème conférence...
Merrion Pharmaceuticals plc Announces Preliminary Results On Phase II Orazol(tm) Study
15 mai 2009 03h00 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Ireland, May 15, 2009 (GLOBE NEWSWIRE) -- Dr. John Fox, of Merrion Pharmaceuticals ("Merrion" or the "Company"), will address the 7th International Cancer Conference in Dublin today, and will...
Merrion Pharmaceuticals Plc Announces Preliminary Results On Phase II Orazol(tm) Study
15 mai 2009 03h00 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Ireland, May 15, 2009 (GLOBE NEWSWIRE) -- Dr. John Fox, of Merrion
Pharmaceuticals ("Merrion" or the "Company"), will address the 7th
International Cancer Conference in Dublin today, and...
Merrion Completes Patient Enrolment in Phase IIb Study -- Results Will be Announced in Q2 2009
10 févr. 2009 04h00 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Ireland, Feb. 10, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc (IEX:MERR), an international specialty pharmaceutical development company, today announces the completion of patient...
Merrion Completes Patient Enrolment in Phase IIb Study -- Results Will be Announced in Q2 2009
10 févr. 2009 04h00 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Ireland, Feb. 10, 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals plc
(IEX:MERR), an international specialty pharmaceutical development company,
today announces the completion of patient...
Press Release
09 févr. 2009 13h47 HE
|
Merrion Pharmaceuticals plc
Mymetics Corporation verkündet Erfolg ihres Präventivimpfstoffes gegen HIV/AIDS
und Start der europäischen Phase 1 von menschlichen klinischen Studien
NYON, Schweiz, 6. Feb. 2009 (GLOBE NEWSWIRE)...
Merrion Pharmaceuticals plc, Communiqué de presse
19 janv. 2009 03h00 HE
|
Merrion Pharmaceuticals plc
Communiqué photo -- Merrion annonce la passation d'un contrat avec Novo
Nordisk, visant à mettre au point une préparation orale de l'agoniste/des
agonistes du récepteur GLP-1 -- Novo Nordisk...
Merrion Pharmaceuticals plc, Comunicado de prensa
19 janv. 2009 03h00 HE
|
Merrion Pharmaceuticals plc
Autorización para publicar fotografías -- Merrion anuncia acuerdo de licencia
con Novo Nordisk para desarrollar fórmulas orales del agonista del receptor
GLP-1(s) -- Novo Nordisk invierte en...
Merrion Pharmaceuticals plc, Comunicato stampa
19 janv. 2009 03h00 HE
|
Merrion Pharmaceuticals plc
Edizione fotografica - Merrion dà annuncio dell'accordo di licenza con
Novo Nordisk per lo sviluppo del composto orale agonista del recettore GLP-1 --
Novo Nordisk investe in azioni di Merrion...
Merrion Pharmaceuticals plc, Pressemitteilung
19 janv. 2009 03h00 HE
|
Merrion Pharmaceuticals plc
DUBLIN, Irland, 19. Jan. 2009 (GLOBE NEWSWIRE) -- Merrion Pharmaceuticals
(IEX:MERR) und Novo Nordisk A/S (NYSE:NVO), ein globaler Marktführer für
Diabetes, haben einen Entwicklungs- und...